Myosin-light-chain phosphatase

Myosin-light-chain phosphatase (MLCP) is an enzyme that plays a crucial role in the regulation of muscle contraction within the body. It is involved in the process of smooth muscle relaxation by dephosphorylating the myosin light chains, which are part of the myosin molecule, a protein essential for muscle contraction. This action counteracts the effect of myosin light chain kinase (MLCK), which phosphorylates the myosin light chains to initiate contraction. Therefore, MLCP is vital for the control of muscle tone and vascular resistance.

Structure

MLCP is a heterotrimeric enzyme, consisting of three subunits: a catalytic subunit of protein phosphatase 1 (PP1c), a myosin-binding subunit (MBS), and a smaller subunit that varies among species. The MBS targets the enzyme to myosin and is crucial for its function in muscle cells.

Function

The primary function of MLCP is to dephosphorylate the regulatory light chains of myosin II, which are phosphorylated by MLCK. This dephosphorylation is essential for the relaxation phase of muscle contraction, particularly in smooth muscle tissue. By controlling the phosphorylation state of the myosin light chains, MLCP regulates smooth muscle contraction and relaxation, affecting blood pressure and flow, airway resistance, and gastrointestinal motility.

Regulation

The activity of MLCP is regulated by several mechanisms, including phosphorylation by various kinases such as Rho-kinase (ROCK), which inhibits MLCP activity, leading to increased muscle contraction. Other factors that influence MLCP activity include intracellular calcium levels and the interaction with specific proteins that can modulate its localization and function.

Clinical Significance

Alterations in MLCP activity have been implicated in various pathological conditions, including hypertension, asthma, and vascular disease. Drugs that affect the RhoA/ROCK pathway, and thereby influence MLCP activity, are under investigation for the treatment of these conditions.

Research

Research on MLCP continues to uncover its complex role in muscle physiology and its potential as a target for therapeutic intervention in diseases characterized by dysregulated smooth muscle contraction.

  [[File:|frameless|alt=]]

EC number	{{{EC_number}}}
CAS number
Alt. names
IntEnz
BRENDA
ExPASy
KEGG
MetaCyc